📦 NDC / package directory — not a drug information page
Naxitamab NDCs, Package Codes, Strengths & Labelers
This page lists NDC package records for Naxitamab products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.
Key stats
4
Package NDCs
5
Products
5
Active listings
0
Discontinued
4
Labelers
2
Strengths
2
Dosage forms
0
With NADAC pricing
By strength, form & labeler
NDC products by strength
By dosage form
Top labelers
Browse records — 5 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| DANYELZA Naxitamab 40 mg/10mL INJECTION | 73042-0201-01 | — | Discontinued | View → |
| DANYELZA Naxitamab 40 mg/10mL INJECTION | 50633-0230-01 | — | On market | View → |
| DANYELZA Naxitamab 40 mg/10mL INJECTION | 50633-0230-01 | — | On market | View → |
| NAXITAMAB 4 g/L SOLUTION, CONCENTRATE | 83266-0000-00 | — | On market | View → |
| Naxitamab 40 mg/10mL INJECTION | 63552-0209-00 | — | On market | View → |
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.